psilocybin-assisted therapy depression trial
Selected indexed studies
- Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. (Psychiatry Res, 2023) [PMID:37844352]
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. (JAMA Psychiatry, 2021) [PMID:33146667]
- Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. (Med, 2024) [PMID:38359838]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. (2023) pubmed
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. (2021) pubmed
- Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial. (2023) pubmed
- Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies. (2023) pubmed
- Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder. (2024) pubmed
- Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. (2023) pubmed
- Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. (2024) pubmed
- Psilocybin-Assisted Compassion Focused Therapy for Depression. (2022) pubmed
- Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial. (2025) pubmed
- Psilocybin for Trauma-Related Disorders. (2022) pubmed